SCHEMBL18883308

SCHEMBL18883308

CCCn1c(C)ccc1-c1ccc(SC)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CHRM1 P11229 1/20 0.47
TBXA2R P21731 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
PDE4A P27815 1/20 0.47
ADRA1A P35348 1/20 0.47
DRD3 P35462 1/20 0.47
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPK1 P28482 3/20 0.37
USP2 O75604 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ESR1 P03372 1/20 0.36
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13633791 0.86 ADORA3 (0.44) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL16558089 0.85 PGR (0.49) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL17747396 0.84 PGR (0.44) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL18700271 0.83 PGR (0.50) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL18888318 0.79 SLC6A2 (0.53) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL15591215 0.78 ALDH1A1 (0.38) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL12471766 0.77 PGR (0.48) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL14360472 0.77 MAPK13 (0.39) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL23983079 0.74 SLC6A2 (0.44) PGRADORA3CHRM1TBXA2RPTGS1
SCHEMBL18413078 0.73 PGR (0.60) PGRADORA3CHRM1TBXA2RPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170144968-A1 PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES ZYDUS LIFESCIENCES LIMITED (IN) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170144968-A1 PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES CYP51A1, LIPA, DHCR7 PGR 3708/4885ADORA3 3898/4885CHRM1 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.